The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sorafenib discontinuation due to toxicity: A literature-based meta-analysis and meta-regression analysis of 18 randomized controlled trials in solid and hematologic malignancies.
Johanna Wassermann
No relevant relationships to disclose
Olivier Huillard
No relevant relationships to disclose
Benoit Rousseau
No relevant relationships to disclose
Julien Peron
No relevant relationships to disclose
Manuel Jorge Rodrigues
No relevant relationships to disclose
Jean-Philippe Spano
No relevant relationships to disclose
Mohamed Bouattour
Honoraria - Bayer